Cannabis (drug)

From Hidden Wiki
(Redirected from Marijuana)
Jump to navigation Jump to search

Template:Pp-move-indef Template:Pp-semi-vandalism Template:Infobox botanical product

Cannabis, also known as marijuana among other names, efn|Also referred to as "pot", "weed", "dope", and "ganja" /ˈɡɑːndʒə/,[1][2][3][4] among many other nicknames ("grass", "herb", "skunk", "Mary Jane", etc.).[5][6][7][8][9] is a psychoactive drug from the Cannabis plant used for medical or recreational purposes.[10][11][12] The main psychoactive part of cannabis is tetrahydrocannabinol (THC), one of 483 known compounds in the plant,[13] including at least 65 other cannabinoids.[14] Cannabis can be used by smoking, vaporizing, within food, or as an extract.[15]

Cannabis has mental and physical effects, such as creating a "high" or "stoned" feeling, a general change in perception, heightened mood, and an increase in appetite.[15][16] Onset of effects is within minutes when smoked, and about 30 to 60 minutes when cooked and eaten.[15][17] They last for between two and six hours.[17] Short-term side effects may include a decrease in short-term memory, dry mouth, impaired motor skills, red eyes, and feelings of paranoia or anxiety.[15][18][19] Long-term side effects may include addiction, decreased mental ability in those who started as teenagers, and behavioral problems in children whose mothers used cannabis during pregnancy.[15] There is a strong relation between cannabis use and the risk of psychosis,[20] though the cause-and-effect is debated.[21]

Cannabis is mostly used for recreation or as a medicinal drug, although it may also be used for spiritual purposes. In 2013, between 128 and 232 million people used cannabis (2.7% to 4.9% of the global population between the ages of 15 and 65).[22] It is the most commonly used illegal drug both in the world and the United States.[15][22] The countries with the highest use among adults Template:As of are Zambia, the United States, Canada, and Nigeria.[23] In 2016, 51% of people in the United States had ever used cannabis.[24] About 12% had used it in the past year, and 7.3% had used it in the past month.[25]

The earliest recorded uses date from the 3rd millennium BC.[26] Since the early 20th century, cannabis has been subject to legal restrictions. The possession, use, and sale of cannabis is illegal in most countries of the world.[27][28] Medical cannabis refers to the physician-recommended use of cannabis, which takes place in Canada, Belgium, Australia, the Netherlands, Germany, Spain, and 33 U.S. states.[29][30] In September 2018, cannabis was legalized in South Africa[31] while Canada legalized recreational use of cannabis in October 2018.[32] Template:TOC limit

Uses

Medical

Template:Main

File:Bodily effects of cannabis.svg
Main short-term physical effects of cannabis

Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; however, there is no single agreed-upon definition.[33][34] The rigorous scientific study of cannabis as a medicine has been hampered by production restrictions and other federal regulations.[35] There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms.[36][37][38] Its use for other medical applications is insufficient for conclusions about safety or efficacy.

Short-term use increases the risk of both minor and major adverse effects.[37] Common side effects include dizziness, feeling tired and vomiting.[37] Long-term effects of cannabis are not clear.[37] Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.[36]

Recreational

Template:Main Cannabis has psychoactive and physiological effects when consumed.[39] The immediate desired effects from consuming cannabis include relaxation and euphoria (the "high" or "stoned" feeling), a general alteration of conscious perception, increased awareness of sensation, increased libido[40] and distortions in the perception of time and space. At higher doses, effects can include altered body image, auditory and/or visual illusions, pseudohallucinations and ataxia from selective impairment of polysynaptic reflexes. In some cases, cannabis can lead to dissociative states such as depersonalization[41][42] and derealization.[43]

File:Sharing a joint.jpg
A group of people sharing a joint

Some immediate undesired side effects include a decrease in short-term memory, dry mouth, impaired motor skills and reddening of the eyes.[44] Aside from a subjective change in perception and mood, the most common short-term physical and neurological effects include increased heart rate, increased appetite and consumption of food, lowered blood pressure, impairment of short-term and working memory,[45][46] psychomotor coordination, and concentration.

Some users may experience an episode of acute psychosis, which usually abates after six hours, but in rare instances, heavy users may find the symptoms continuing for many days.[47] A reduced quality of life is associated with heavy cannabis use, although the relationship is inconsistent and weaker than for tobacco and other substances.[48] It is unclear, however, if the relationship is cause and effect.[48]

On October 17, 2018, Canada legalized cannabis for recreational adult use[49] making it the second country in the world to do so after Uruguay and the first G7 nation.[50] The Canadian Licensed Producer system may become the Gold Standard in the world for safe and secure cannabis production,[51] including provisions for a robust craft cannabis industry where many expect opportunities for experimenting with different strains.[52] Laws around use vary from province to province including age limits, retail structure, and growing at home.[49]

Spiritual

Template:Main Cannabis has held sacred status in several religions. It has been used in an entheogenic context – a chemical substance used in a religious, shamanic, or spiritual context[53] - in the Indian subcontinent since the Vedic period dating back to approximately 1500 BCE, but perhaps as far back as 2000 BCE. There are several references in Greek mythology to a powerful drug that eliminated anguish and sorrow. Herodotus wrote about early ceremonial practices by the Scythians, thought to have occurred from the 5th to 2nd century BCE. In modern culture the spiritual use of cannabis has been spread by the disciples of the Rastafari movement who use cannabis as a sacrament and as an aid to meditation. The earliest known reports regarding the sacred status of cannabis in the Indian subcontinent come from the Atharva Veda estimated to have been written sometime around 2000–1400 BCE.[54]

Available forms

Template:Main

File:Unrolled joint.jpg
A joint prior to rolling, with a paper handmade filter on the left

Cannabis is consumed in many different ways:[55]

  • smoking, which typically involves burning and inhaling vaporized cannabinoids ("smoke") from small pipes, bongs (portable versions of hookahs with a water chamber), paper-wrapped joints or tobacco-leaf-wrapped blunts, and other items.[56]
  • vaporizer, which heats any form of cannabis to Template:Convert,[57] causing the active ingredients to evaporate into a vapor without burning the plant material (the boiling point of THC is Template:Convert at atmospheric pressure).[58]
  • cannabis tea, which contains relatively small concentrations of THC because THC is an oil (lipophilic) and is only slightly water-soluble (with a solubility of 2.8 mg per liter).[59] Cannabis tea is made by first adding a saturated fat to hot water (e.g. cream or any milk except skim) with a small amount of cannabis.[60]
  • edibles, where cannabis is added as an ingredient to one of a variety of foods, including butter and baked goods. In India it is commonly made into a beverage, bhang.
  • capsules, typically containing cannabis oil, and other dietary supplement products, for which some 220 were approved in Canada in 2018.[32]

Adverse effects

Template:See also Template:Further

File:Rational harm assessment of drugs radar plot.svg
Addiction experts in psychiatry, chemistry, pharmacology, forensic science, epidemiology, and the police and legal services engaged in delphic analysis regarding 20 popular recreational drugs. Cannabis was ranked 11th in dependence, 17th in physical harm, and 10th in social harm.[61]

Short term

Acute effects may include anxiety and panic, impaired attention and memory, an increased risk of psychotic symptoms, Template:Efn the inability to think clearly, and an increased risk of accidents.[62][63][64] Cannabis impaired a person's driving ability, and THC was the illicit drug most frequently found in the blood of drivers who have been involved in vehicle crashes. Those with THC in their system were from three to seven times more likely to be the cause of the accident than those who had not used either cannabis or alcohol, although its role is not necessarily causal because THC stays in the bloodstream for days to weeks after intoxication.[65][66]Template:Efn

According to the United States Department of Health and Human Services, there were 455,000 emergency room visits associated with cannabis use in 2011. These statistics include visits in which the patient was treated for a condition induced by or related to recent cannabis use. The drug use must be "implicated" in the emergency department visit, but does not need to be the direct cause of the visit. Most of the illicit drug emergency room visits involved multiple drugs.[67] In 129,000 cases, cannabis was the only implicated drug.[68][69]

The short term effects of cannabis can be altered if it has been laced with opioid drugs such as heroin or fentanyl.[70] The added drugs are meant to enhance the psychoactive properties, add to its weight, and increase profitability, despite the increased danger of overdose.[71][72]Template:Efn

Long term

Heavy, long-term exposure to marijuana may have biologically based physical, mental, behavioral and social health consequences and may be "associated with diseases of the liver (particularly with co-existing hepatitis C), lungs, heart, and vasculature".[73] It is recommended that cannabis use be stopped before and during pregnancy as it can result in negative outcomes for both the mother and baby.[74][75] However, maternal use of marijuana during pregnancy does not appear to be associated with low birth weight or early delivery after controlling for tobacco use and other confounding factors.[76] A 2014 review found that while cannabis use may be less harmful than alcohol use, the recommendation to substitute it for problematic drinking was premature without further study.[77] Various surveys conducted between 2015 and 2019 found that many users of cannabis substitute it for prescription drugs (including opioids), alcohol, and tobacco; most of those who used it in place of alcohol or tobacco either reduced or stopped their intake of the latter substances.[78]

A limited number of studies have examined the effects of cannabis smoking on the respiratory system.[79] Chronic heavy marijuana smoking is associated with coughing, production of sputum, wheezing, and other symptoms of chronic bronchitis.[62] The available evidence does not support a causal relationship between cannabis use and chronic obstructive pulmonary disease.[80] Short-term use of cannabis is associated with bronchodilation.[81] Other side effects of cannabis use include cannabinoid hyperemesis syndrome.[82]

Cannabis smoke contains thousands of organic and inorganic chemical compounds. This tar is chemically similar to that found in tobacco smoke,[83] and over fifty known carcinogens have been identified in cannabis smoke,[84] including; nitrosamines, reactive aldehydes, and polycylic hydrocarbons, including benz[a]pyrene.[85] Cannabis smoke is also inhaled more deeply than is tobacco smoke.[86] Template:As of, there is no consensus regarding whether cannabis smoking is associated with an increased risk of cancer.[87] Light and moderate use of cannabis is not believed to increase risk of lung or upper airway cancer. Evidence for causing these cancers is mixed concerning heavy, long-term use. In general there are far lower risks of pulmonary complications for regular cannabis smokers when compared with those of tobacco.[88] A 2015 review found an association between cannabis use and the development of testicular germ cell tumors (TGCTs), particularly non-seminoma TGCTs.[89] A 2015 analysis of six studies found little evidence that long-term or regular cannabis smoking was associated with lung cancer risk, though it could not rule out whether an association with heavy smoking exists.[90] Another 2015 meta-analysis found no association between lifetime cannabis use and risk of head or neck cancer.[91] Combustion products are not present when using a vaporizer, consuming THC in pill form, or consuming cannabis foods.[92]

There is concern that cannabis may contribute to cardiovascular disease,[93] but as of 2018, evidence of this relationship was unclear.[94][95] Cannabis is believed to be an aggravating factor in rare cases of arteritis, a serious condition that in some cases leads to amputation. Because 97% of case-reports also smoked tobacco, a formal association with cannabis could not be made. If cannabis arteritis turns out to be a distinct clinical entity, it might be the consequence of vasoconstrictor activity observed from delta-8-THC and delta-9-THC.[96] Other serious cardiovascular events including myocardial infarction, stroke,[97] sudden cardiac death, and cardiomyopathy have been reported to be temporally associated with cannabis use. Research in these events is complicated because cannabis is often used in conjunction with tobacco, and drugs such as alcohol and cocaine.[98] These putative effects can be taken in context of a wide range of cardiovascular phenomena regulated by the endocannabinoid system and an overall role of cannabis in causing decreased peripheral resistance and increased cardiac output, which potentially could pose a threat to those with cardiovascular disease.[99] There is some evidence from case reports that cannabis use may provoke fatal cardiovascular events in young people who have not been diagnosed with cardiovascular disease.[100] Smoking cannabis has also been shown to increase the risk of myocardial infarction by 4.8 times for the 60 minutes after consumption.[101]

Neuroimaging

Although global abnormalities in white matter and grey matter are not associated with cannabis abuse, reduced hippocampal volume is consistently found. Amygdalar abnormalities are sometimes reported, although findings are inconsistent.[102][103][104] Preliminary evidence suggests that this effect is largely mediated by THC, and that CBD may even have a protective effect.[105]

Cannabis use is associated with increased recruitment of task-related areas, such as the dorsolateral prefrontal cortex, which is thought to reflect compensatory activity due to reduced processing efficiency.[104][103][106] Cannabis use is also associated with downregulation of CB1 receptors. The magnitude of down regulation is associated with cumulative cannabis exposure, and is reversed after one month of abstinence.[107][108][109] There is limited evidence that chronic cannabis use can reduce levels of glutamate metabolites in the human brain.[110]

Cognition

A 2015 meta analysis found that, although a longer period of abstinence was associated with smaller magnitudes of impairment, both retrospective and prospective memory were impaired in cannabis users. The authors concluded that some, but not all, of the deficits associated with cannabis use were reversible.[111] A 2012 meta analyses found that deficits in most domains of cognition persisted beyond the acute period of intoxication, but was not evident in studies where subjects were abstinent for more than 25 days.[112] Few high quality studies have been performed on the long-term effects of cannabis on cognition, and results were generally inconsistent.[113] Furthermore, effect sizes of significant findings were generally small.[112] One review concluded that, although most cognitive faculties were unimpaired by cannabis use, residual deficits occurred in executive functions.[114] Impairments in executive functioning are most consistently found in older populations, which may reflect heavier cannabis exposure, or developmental effects associated with adolescent cannabis use.[115] One review found three prospective cohort studies that examined the relationship between self reported cannabis use and intelligence quotient (IQ). The study following the largest number of heavy cannabis users reported that IQ declined between ages 7–13 and age 38. Poorer school performance and increased incidence of leaving school early were both associated with cannabis use, although a causal relationship was not established.[107] Cannabis users demonstrated increased activity in task-related brain regions, consistent with reduced processing efficiency.[116]

Psychiatric

Template:See also At an epidemiological level, a dose–response relationship exists between cannabis use and increased risk of psychosis[117][118][119] and earlier onset of psychosis.[120] Although the epidemiological association is robust, evidence to prove a causal relationship is lacking.[121] But a biological causal pathway is plausible, especially if there is a genetic predisposition to mental illness, in which case cannabis may be a trigger.[122]Template:Better source

It is not clear whether cannabis use affects the rate of suicide.[123][124] Cannabis may also increase the risk of depression, but insufficient research has been performed to draw a conclusion.[125][118] Cannabis use is associated with increased risk of anxiety disorders, although causality has not been established.[126]

A February 2019 review found that cannabis use during adolescence was associated with an increased risk of developing depression and suicidal behavior later in life, while finding no effect on anxiety.[127]

Reinforcement disorders

Template:Main About 9% of those who experiment with marijuana eventually become dependent according to DSM-IV (1994) criteria.[69] A 2013 review estimates daily use is associated with a 10-20% rate of dependence.[36] The highest risk of cannabis dependence is found in those with a history of poor academic achievement, deviant behavior in childhood and adolescence, rebelliousness, poor parental relationships, or a parental history of drug and alcohol problems.[128] Of daily users, about 50% experience withdrawal upon cessation of use (i.e. are dependent), characterized by sleep problems, irritability, dysphoria, and craving.[107] Cannabis withdrawal is less severe than withdrawal from alcohol.[129]

According to DSM-V criteria, 9% of those who are exposed to cannabis develop cannabis use disorder, compared to 20% for cocaine, 23% for alcohol and 68% for nicotine. Cannabis abuse disorder in the DSM-V involves a combination of DSM-IV criteria for cannabis abuse and dependence, plus the addition of craving, minus the criterion related to legal troubles.[107]

Overdose

THC, the principal psychoactive constituent of the cannabis plant, has low toxicity. The dose of THC needed to kill 50% of tested rodents is extremely high. Cannabis has not been reported to cause fatal overdose in humans.[123]

Pharmacology

Mechanism of action

Template:See also The high lipid-solubility of cannabinoids results in their persisting in the body for long periods of time.[130] Even after a single administration of THC, detectable levels of THC can be found in the body for weeks or longer (depending on the amount administered and the sensitivity of the assessment method).[130] A number of investigators have suggested that this is an important factor in marijuana's effects, perhaps because cannabinoids may accumulate in the body, particularly in the lipid membranes of neurons.[131]

Not until the end of the 20th century was the specific mechanism of action of THC at the neuronal level studied.Template:Citation needed Researchers have subsequently confirmed that THC exerts its most prominent effects via its actions on two types of cannabinoid receptors, the CB1 receptor and the CB2 receptor, both of which are G protein-coupled receptors.[132] The CB1 receptor is found primarily in the brain as well as in some peripheral tissues, and the CB2 receptor is found primarily in peripheral tissues, but is also expressed in neuroglial cells.[133] THC appears to alter mood and cognition through its agonist actions on the CB1 receptors, which inhibit a secondary messenger system (adenylate cyclase) in a dose-dependent manner. These actions can be blocked by the selective CB1 receptor antagonist rimonabant (SR141716), which has been shown in clinical trials to be an effective treatment for smoking cessation, weight loss, and as a means of controlling or reducing metabolic syndrome risk factors.[134] However, due to the dysphoric effect of CB1 receptor antagonists, this drug is often discontinued due to these side effects.[135]

Via CB1 receptor activation, THC indirectly increases dopamine release and produces psychotropic effects.[136] Cannabidiol (CBD) also acts as an allosteric modulator of the μ- and δ-opioid receptors.[137] THC also potentiates the effects of the glycine receptors.[138] It is unknown if or how these actions contribute to the effects of cannabis.[139]

Chemistry

Detection in body fluids

Template:Main

THC and its major (inactive) metabolite, THC-COOH, can be measured in blood, urine, hair, oral fluid or sweat using chromatographic techniques as part of a drug use testing program or a forensic investigation of a traffic or other criminal offense.[47] The concentrations obtained from such analyses can often be helpful in distinguishing active use from passive exposure, elapsed time since use, and extent or duration of use. These tests cannot, however, distinguish authorized cannabis smoking for medical purposes from unauthorized recreational smoking.[140] Commercial cannabinoid immunoassays, often employed as the initial screening method when testing physiological specimens for marijuana presence, have different degrees of cross-reactivity with THC and its metabolites.[141] Urine contains predominantly THC-COOH, while hair, oral fluid and sweat contain primarily THC.[47] Blood may contain both substances, with the relative amounts dependent on the recency and extent of usage.[47]

The Duquenois–Levine test is commonly used as a screening test in the field, but it cannot definitively confirm the presence of cannabis, as a large range of substances have been shown to give false positives.[142] Despite this, it is common in the United States for prosecutors to seek plea bargains on the basis of positive D–L tests, claiming them to be conclusive, or even to seek conviction without the use of gas chromatography confirmation, which can only be done in the lab.[143] In 2011, researchers at John Jay College of Criminal Justice reported that dietary zinc supplements can mask the presence of THC and other drugs in urine.[144] However, a 2013 study conducted by researchers at the University of Utah School of Medicine refute the possibility of self-administered zinc producing false-negative urine drug tests.[145]

Varieties and strains

File:Cannab2 new.png
Types of cannabis

CBD is a 5-HT1A receptor agonist, which may also contribute to an anxiolytic effect.[146] This likely means the high concentrations of CBD found in Cannabis indica mitigate the anxiogenic effect of THC significantly.[146] The cannabis industry claims that sativa strains provide a more stimulating psychoactive high while indica strains are more sedating with a body high.[147] However this is disputed by researchers.[148]

Psychoactive ingredients

According to the United Nations Office on Drugs and Crime (UNODC), "the amount of THC present in a cannabis sample is generally used as a measure of cannabis potency."[149] The three main forms of cannabis products are the flower, resin (hashish), and oil (hash oil). The UNODC states that cannabis often contains 5% THC content, resin "can contain up to 20% THC content", and that "Cannabis oil may contain more than 60% THC content."[149]

A 2012 review found that the THC content in marijuana had increased worldwide from 1970 to 2009.[150] It is unclear, however, whether the increase in THC content has caused people to consume more THC or if users adjust based on the potency of the cannabis. It is likely that the higher THC content allows people to ingest less tar. At the same time, CBD levels in seized samples have lowered, in part because of the desire to produce higher THC levels and because more illegal growers cultivate indoors using artificial lights. This helps avoid detection but reduces the CBD production of the plant.[151]

Australia's National Cannabis Prevention and Information Centre (NCPIC) states that the buds (flowers) of the female cannabis plant contain the highest concentration of THC, followed by the leaves. The stalks and seeds have "much lower THC levels".[152] The UN states that leaves can contain ten times less THC than the buds, and the stalks one hundred times less THC.[149]

After revisions to cannabis scheduling in the UK, the government moved cannabis back from a class C to a class B drug. A purported reason was the appearance of high potency cannabis. They believe skunk accounts for between 70 and 80% of samples seized by police[153] (despite the fact that skunk can sometimes be incorrectly mistaken for all types of herbal cannabis).[154][155] Extracts such as hashish and hash oil typically contain more THC than high potency cannabis flowers.[156]

Preparations

Marijuana

Template:Further Marijuana or marihuana (herbal cannabis),[157] consists of the dried flowers and subtending leaves and stems of the female Cannabis plant.[158][159][160][161] This is the most widely consumed form,[161] containing 3% to 20% THC,[162] with reports of up-to 33% THC.[163] This is the stock material from which all other preparations are derived. Although herbal cannabis and industrial hemp derive from the same species and contain the psychoactive component (THC), they are distinct strains with unique biochemical compositions and uses. Hemp has lower concentrations of THC and higher concentrations of CBD, which decreases the psychoactive effects[164][165]

Kief

Template:Main Kief is a powder, rich in trichomes,[166] which can be sifted from the leaves and flowers of cannabis plants and either consumed in powder form or compressed to produce cakes of hashish.[167] The word "kif" derives from colloquial Arabic {{#invoke:lang|lang}} Template:Transl, meaning pleasure.[168]

Hashish

Template:Main

Hashish (also spelled hasheesh, hashisha, or simply hash) is a concentrated resin cake or ball produced from pressed kief, the detached trichomes and fine material that falls off cannabis flowers and leaves.[169] or from scraping the resin from the surface of the plants and rolling it into balls. It varies in color from black to golden brown depending upon purity and variety of cultivar it was obtained from.[170] It can be consumed orally or smoked, and is also vaporised, or 'vaped'.[171] The term "rosin hash" refers to a high quality solventless product obtained through heat and pressure.[172]

Tincture

Template:Main

Cannabinoids can be extracted from cannabis plant matter using high-proof spirits (often grain alcohol) to create a tincture, often referred to as "green dragon".[173] Nabiximols is a branded product name from a tincture manufacturing pharmaceutical company.[174]

Hash oil

Template:Main

Hash oil is a resinous matrix of cannabinoids obtained from the Cannabis plant by solvent extraction,[175] formed into a hardened or viscous mass.[176] Hash oil can be the most potent of the main cannabis products because of its high level of psychoactive compound per its volume, which can vary depending on the plant's mix of essential oils and psychoactive compounds.[177] Butane and supercritical carbon dioxide hash oil have become popular in recent years.[178]

Infusions

There are many varieties of cannabis infusions owing to the variety of non-volatile solvents used.[179] The plant material is mixed with the solvent and then pressed and filtered to express the oils of the plant into the solvent. Examples of solvents used in this process are cocoa butter, dairy butter, cooking oil, glycerine, and skin moisturizers. Depending on the solvent, these may be used in cannabis foods or applied topically.[180]

Medical use

Template:Further

Medical marijuana refers to the use of the Cannabis plant as a physician-recommended herbal therapy as well as synthetic[181] THC and cannabinoids. So far, the medical use of cannabis is legal only in a limited number of territories, including Canada,[32] Belgium, Australia, the Netherlands, Spain, and many U.S. states. This usage generally requires a prescription, and distribution is usually done within a framework defined by local laws. There is evidence supporting the use of cannabis or its derivatives in the treatment of chemotherapy-induced nausea and vomiting, neuropathic pain, and multiple sclerosis. Lower levels of evidence support its use for AIDS wasting syndrome, epilepsy, rheumatoid arthritis, and glaucoma.[69]

File:Cannabissativadior.jpg
Cannabis sativa from Vienna Dioscurides, c. 512 CE

History

Template:See also

Cannabis is indigenous to Central Asia[182] and the Indian subcontinent,[183] and its use for fabric and rope dates back to the Neolithic age in China and Japan.[184][185] It is unclear when cannabis first became known for its psychoactive properties; some scholars suggest that the ancient Indian drug soma, mentioned in the Vedas, was cannabis, although this theory is disputed.[186]

Cannabis was known to the ancient Assyrians, who discovered its psychoactive properties through the Iranians.[187] Using it in some religious ceremonies, they called it qunubu (meaning "way to produce smoke"), a probable origin of the modern word "cannabis".[188] The Iranians also introduced cannabis to the Scythians, Thracians and Dacians, whose shamans (the kapnobatai—"those who walk on smoke/clouds") burned cannabis flowers to induce trance.[189] The plant was used in China before 2800 BC, and found therapeutic use in India by 1000 BC, where it was used in food and drink, including bhang.[190][191]

Cannabis has an ancient history of ritual use and is found in pharmacological cults around the world. Hemp seeds discovered by archaeologists at Pazyryk suggest early ceremonial practices like eating by the Scythians occurred during the 5th to 2nd century BC, confirming previous historical reports by Herodotus.[192] It was used by Muslims in various Sufi orders as early as the Mamluk period, for example by the Qalandars.[193] Smoking pipes uncovered in Ethiopia and carbon-dated to around c. AD 1320 were found to have traces of cannabis.[194]

Following an 1836–1840 travel in North Africa and the Middle East, French physician Jacques-Joseph Moreau wrote on the psychological effects of cannabis use; he was a member of Paris' Club des Hashischins.Template:Citation needed In 1842, Irish physician William Brooke O'Shaughnessy, who had studied the drug while working as a medical officer in Bengal with the East India company, brought a quantity of cannabis with him on his return to Britain, provoking renewed interest in the West.[195] Examples of classic literature of the period featuring cannabis include Les paradis artificiels (1860) by Charles Baudelaire and The Hasheesh Eater (1857) by Fitz Hugh Ludlow.

File:Killerdrug.jpg
Cannabis propaganda from 1935

Cannabis was criminalized in various countries beginning in the 19th century. The British colonies of Mauritius banned cannabis in 1840 over concerns on its effect on Indian indentured workers;[196] the same occurred in British Singapore in 1870.[197] In the United States, the first restrictions on sale of cannabis came in 1906 (in District of Columbia).[198] It was outlawed in Jamaica (then a British colony) in 1913, in South Africa in 1922, and in the United Kingdom and New Zealand in the 1920s.[199] Canada criminalized cannabis in The Opium and Narcotic Drug Act, 1923,[200] before any reports of the use of the drug in Canada, but eventually legalized its consumption for recreational and medicinal purposes in 2018.[32]

File:Drug bottle containing cannabis.jpg
Cannabis indica fluid extract, American Druggists Syndicate (Template:Nowrap)

In 1925, a compromise was made at an international conference in The Hague about the International Opium Convention that banned exportation of "Indian hemp" to countries that had prohibited its use, and requiring importing countries to issue certificates approving the importation and stating that the shipment was required "exclusively for medical or scientific purposes". It also required parties to "exercise an effective control of such a nature as to prevent the illicit international traffic in Indian hemp and especially in the resin".[201][202] In the United States in 1937, the Marihuana Tax Act was passed,[203] and prohibited the production of hemp in addition to cannabis.

In 1972, the Dutch government divided drugs into more- and less-dangerous categories, with cannabis being in the lesser category. Accordingly, possession of 30 grams or less was made a misdemeanor.[204] Cannabis has been available for recreational use in coffee shops since 1976.[205] Cannabis products are only sold openly in certain local "coffeeshops" and possession of up to 5 grams for personal use is decriminalised, however: the police may still confiscate it, which often happens in car checks near the border. Other types of sales and transportation are not permitted, although the general approach toward cannabis was lenient even before official decriminalisation.[206][207][208]

In Uruguay, President Jose Mujica signed legislation to legalize recreational cannabis in December 2013, making Uruguay the first country in the modern era to legalize cannabis. In August 2014, Uruguay legalized growing up to six plants at home, as well as the formation of growing clubs, and a state-controlled marijuana dispensary regime.

As of October 17, 2018 when recreational use of cannabis was legalized in Canada, dietary supplements for human use and veterinary health products containing not more than 10 parts per million of THC extract were approved for marketing; Nabiximols (as Sativex) is used as a prescription drug in Canada.[32]

The United Nations' World Drug Report stated that cannabis "was the world's most widely produced, trafficked, and consumed drug in the world in 2010", and estimated between 128 million and 238 million users globally in 2015.[209][210]

Society and culture

Template:See also

Legal status

Template:Main Template:See also

Since the beginning of the 20th century, most countries have enacted laws against the cultivation, possession or transfer of cannabis.[211] These laws have impacted adversely on cannabis cultivation for non-recreational purposes, but there are many regions where handling of cannabis is legal or licensed. Many jurisdictions have lessened the penalties for possession of small quantities of cannabis so that it is punished by confiscation and sometimes a fine, rather than imprisonment, focusing more on those who traffic the drug on the black market.

In some areas where cannabis use had been historically tolerated, new restrictions were instituted, such as the closing of cannabis coffee shops near the borders of the Netherlands,[212] and closing of coffee shops near secondary schools in the Netherlands.[213] In Copenhagen, Denmark in 2014, mayor Frank Jensen discussed possibilities for the city to legalize cannabis production and commerce.[214]

Some jurisdictions use free voluntary treatment programs and/or mandatory treatment programs for frequent known users. Simple possession can carry long prison terms in some countries, particularly in East Asia, where the sale of cannabis may lead to a sentence of life in prison or even execution. Political parties, non-profit organizations, and causes based on the legalization of medical cannabis and/or legalizing the plant entirely (with some restrictions) have emerged in such countries as China and Thailand.[215][216]

In December 2012, the U.S. state of Washington became the first state to officially legalize cannabis in a state law (Washington Initiative 502) (but still illegal by federal law),[217] with the state of Colorado following close behind (Colorado Amendment 64).[218] On January 1, 2013, the first marijuana "club" for private marijuana smoking (no buying or selling, however) was allowed for the first time in Colorado.[219] The California Supreme Court decided in May 2013 that local governments can ban medical marijuana dispensaries despite a state law in California that permits the use of cannabis for medical purposes. At least 180 cities across California have enacted bans in recent years.[220]

In December 2013, Uruguay became the first country to legalize growing, sale and use of cannabis.[221] After a long delay in implementing the retail component of the law, in 2017 sixteen pharmacies were authorized to sell cannabis commercially.[222] On June 19, 2018, the Canadian Senate passed a bill and the Prime Minister announced the effective legalization date as October 17, 2018.[32][223] Canada is the second nation to legalize the drug.[224]

In November 2015, Uttarakhand became the first state of India to legalize the cultivation of hemp for industrial purposes.[225] Usage within the Hindu and Buddhist cultures of the Indian subcontinent is common, with many street vendors in India openly selling products infused with cannabis, and traditional medical practitioners in Sri Lanka selling products infused with cannabis for recreational purposes and well as for religious celebrations.[226] It was criminalized in the Indian subcontinent by the Dutch and then the British. India and Sri Lanka have allowed cannabis to be taken in the context of traditional culture for recreational/celebratory purposes and also for medicinal purposes.[226]

On October 17, 2015, Australian health minister Sussan Ley presented a new law that will allow the cultivation of cannabis for scientific research and medical trials on patients.[227]

As the drug has increasingly come to be seen as a health issue instead of criminal behavior, marijuana has also been legalized or decriminalized in: Czech Republic,[228] Colombia,[229][230] Ecuador,[231][232][233] Mexico,[234][235] Portugal,[236] South Africa[237] and Canada.[32]

Usage

Template:Global estimates of illicit drug users In 2013, between 128 and 232 million people used cannabis (2.7% to 4.9% of the global population between the ages of 15 and 65).[22] Cannabis is by far the most widely used illicit substance.[238]

United States

Between 1973 and 1978, eleven states decriminalized marijuana.[239] In 2001, Nevada reduced marijuana possession to a misdemeanor and since 2012, several other states have decriminalized and even legalized marijuana.[239]

In 2015, almost half of the people in the United States had tried marijuana, 12% had used it in the past year, and 7.3% had used it in the past month.[25] In 2014, daily marijuana use amongst US college students had reached its highest level since records began in 1980, rising from 3.5% in 2007 to 5.9% in 2014 and had surpassed daily cigarette use.[240]

In the US, men are over twice as likely to use marijuana as women and 18-29 year-olds are six times more likely to use as over 65-year-olds.[241] In 2015, a record 44% of the US population has tried marijuana in their lifetime, an increase from 38% in 2013 and 33% in 1985.[241]

Marijuana use in the United States is three times above the global average, but in line with other Western democracies. 44% of American 12th graders have tried the drug at least once, and the typical age of first-use is 16, similar to the typical age of first-use for alcohol but lower than the first-use age for other illicit drugs.[238]

Economics

Production

Template:Main

It is often claimed by growers and breeders of herbal cannabis that advances in breeding and cultivation techniques have increased the potency of cannabis since the late 1960s and early '70s when THC was first discovered and understood. However, potent seedless cannabis such as "Thai sticks" were already available at that time. Sinsemilla (Spanish for "without seed") is the dried, seedless inflorescences of female cannabis plants. Because THC production drops off once pollination occurs, the male plants (which produce little THC themselves) are eliminated before they shed pollen to prevent pollination. Advanced cultivation techniques such as hydroponics, cloning, high-intensity artificial lighting, and the sea of green method are frequently employed as a response (in part) to prohibition enforcement efforts that make outdoor cultivation more risky. It is often cited that the average levels of THC in cannabis sold in the United States rose dramatically between the 1970s and 2000, but such statements are likely skewed because undue weight is given to much more expensive and potent, but less prevalent samples.[242]

Template:Anchor "Skunk" refers to several named strains of potent cannabis, grown through selective breeding and sometimes hydroponics. It is a cross-breed of Cannabis sativa and C. indica (although other strains of this mix exist in abundance). Skunk cannabis potency ranges usually from 6% to 15% and rarely as high as 20%. The average THC level in coffee shops in the Netherlands is about 18–19%.[243]

Price

The price or street value of cannabis varies widely depending on geographic area and potency.[244]

In the United States, cannabis is overall the number four value crop, and is number one or two in many states including California, New York and Florida, averaging Template:Convert.[245][246] Some believe it generates an estimated $36 billion market.[247] Some have argued that this estimate is methodologically flawed, and makes unrealistic assumptions about the level of marijuana consumption. Other estimates claiming to correct for this flaw claim that the market is between $2.1-$4.3 billion.[238] The United Nations Office on Drugs and Crime claims in its 2008 World Drug Report that typical U.S. retail prices are $10–15 per gram (approximately $280–420 per ounce). Street prices in North America are known to range from about Template:Convert, depending on quality.[248]

The European Monitoring Centre for Drugs and Drug Addiction reports that typical retail prices in Europe for cannabis varies from €2 to €20 per gram, with a majority of European countries reporting prices in the range €4–10.[249]

Gateway drug

Template:Main The Gateway Hypothesis states that cannabis use increases the probability of trying "harder" drugs. The hypothesis has been hotly debated as it is regarded by some as the primary rationale for the United States prohibition on cannabis use.[250][251] A Pew Research Center poll found that political opposition to marijuana use was significantly associated with concerns about health effects and whether legalization would increase marijuana use by children.[252]

Some studies state that while there is no proof for the gateway hypothesis,[253] young cannabis users should still be considered as a risk group for intervention programs.[254] Other findings indicate that hard drug users are likely to be poly-drug users, and that interventions must address the use of multiple drugs instead of a single hard drug.[255] Almost two-thirds of the poly drug users in the "2009/10 Scottish Crime and Justice Survey" used cannabis.[256]

The gateway effect may appear due to social factors involved in using any illegal drug. Because of the illegal status of cannabis, its consumers are likely to find themselves in situations allowing them to acquaint with individuals using or selling other illegal drugs.[257][258] Utilizing this argument some studies have shown that alcohol and tobacco may additionally be regarded as gateway drugs;[259] however, a more parsimonious explanation could be that cannabis is simply more readily available (and at an earlier age) than illegal hard drugs. In turn alcohol and tobacco are easier to obtain at an earlier point than is cannabis (though the reverse may be true in some areas), thus leading to the "gateway sequence" in those individuals since they are most likely to experiment with any drug offered.[250]

An alternative to the gateway hypothesis is the common liability to addiction (CLA) theory. It states that some individuals are, for various reasons, willing to try multiple recreational substances. The "gateway" drugs are merely those that are (usually) available at an earlier age than the harder drugs. Researchers have noted in an extensive review that it is dangerous to present the sequence of events described in gateway "theory" in causative terms as this hinders both research and intervention.[260]

Research

Template:Further

Cannabis research is challenging since the plant is illegal in most countries.[261][262][263][264][265] Research-grade samples of the drug are difficult to obtain for research purposes, unless granted under authority of national governments.

There are also other difficulties in researching the effects of cannabis. Many people who smoke cannabis also smoke tobacco.[266] This causes confounding factors, where questions arise as to whether the tobacco, the cannabis, or both that have caused a cancer. Another difficulty researchers have is in recruiting people who smoke cannabis into studies. Because cannabis is an illegal drug in many countries, people may be reluctant to take part in research, and if they do agree to take part, they may not say how much cannabis they actually smoke.[267]

A 2015 review found that the use of high CBD-to-THC strains of cannabis showed significantly fewer positive symptoms such as delusions and hallucinations, better cognitive function and both lower risk for developing psychosis, as well as a later age of onset of the illness, compared to cannabis with low CBD-to-THC ratios.[268] A 2014 Cochrane review found that research was insufficient to determine the safety and efficacy to using cannabis to treat schizophrenia or psychosis.[269] Template:As of, the molecular mechanisms for the anti-inflammatory and possible pain relieving effects of cannabis are under preliminary research.[270]

By country

Canada

Template:As of when recreational use of cannabis was legalized in Canada, some 220 dietary supplements and 19 veterinary health products containing not more than 10 parts per million of THC extract were approved with general health claims for treating minor conditions.[32]

United States

Cannabis use started to become popular in the United States in the 1970s.[241] Support for legalization has increased in the United States and several U.S. states have legalized recreational or medical use.[271] A 2018 Social Science Research study found that the main determinants of such changes in attitudes toward marijuana regulation since the 1990s were changes in media framing of marijuana, a decline in perception of the riskiness of marijuana, a decline in overall punitiveness, and a decrease in religious affiliation. [272]

South Africa

Private use of cannabis was legalized in September 2018 after a unanimous decision by the Constitutional Court in Johannesburg.[273] South Africa is the world's third largest producer of cannabis,[274] and the plant has historically been used by traditional healers[275] and Rastafari.[276]

See also

References

Footnotes Template:Notelist

Citations

1 }}
     | references-column-width 
     | references-column-count references-column-count-{{#if:1|{{{1}}}}} }}
   | {{#if: 
     | references-column-width }} }}" style="{{#if: 
   | {{#iferror: {{#ifexpr: 1 > 1 }}
     | Template:Column-width
     | Template:Column-count }}
   | {{#if: 
     | Template:Column-width }} }} list-style-type: {{#switch: 
   | upper-alpha
   | upper-roman
   | lower-alpha
   | lower-greek
   | lower-roman = {{{group}}}
   | #default = decimal}};">
  1. Cite journal|url=http://www.merriam-webster.com/dictionary/pot%7Ctitle=Pot – Definition|publisher=Merriam-Webster Dictionary|access-date=9 October 2012
  2. Cite journal |url=http://www.merriam-webster.com/dictionary/weed%7Ctitle=Weed – Definition|publisher=Merriam-Webster Dictionary |access-date=9 October 2012
  3. cite journal|url=https://www.merriam-webster.com/dictionary/dope |title=Dope – Definition|publisher=Merriam-Webster Dictionary|access-date=17 July 2017
  4. Cite journal |url=https://www.merriam-webster.com/dictionary/ganja |title=Ganja – Definition |publisher=Merriam-Webster Dictionary|access-date=17 July 2017
  5. cite book|first1=Pedro|last1=Ruiz|first2=Eric C.|last2=Strain|name-list-format=vanc|title=Substance Abuse: A Comprehensive Textbook|url=https://books.google.com/books?id=w4ZUJAdleTsC&pg=PA214%7Cyear=2011%7Cpublisher=Lippincott Williams & Wilkins|isbn=978-1-60547-277-5|page=214}}
  6. Template:Cite journal
  7. Template:Cite journal
  8. Template:Cite bookSee also article on Marijuana as a word.
  9. Template:ShorterOxfordEnglishDictionary
  10. Template:Cite book
  11. Template:Cite book
  12. Template:Cite book
  13. 15.0 15.1 15.2 15.3 15.4 15.5 Template:Cite web
  14. Template:Cite web
  15. 17.0 17.1 Template:Cite book
  16. Template:Cite web
  17. Template:Cite journal
  18. Template:Cite journal
  19. Template:Cite journal
  20. 22.0 22.1 22.2 Template:Cite book
  21. Template:Cite web
  22. Template:Cite web
  23. 25.0 25.1 Template:Cite web
  24. Template:Cite book
  25. Template:Cite web
  26. Template:Cite book
  27. Template:Cite web
  28. Template:Cite web
  29. Template:Cite web
  30. 32.0 32.1 32.2 32.3 32.4 32.5 32.6 32.7 Template:Cite web
  31. Template:Cite journal
  32. Template:Cite web
  33. Template:Cite journal
  34. 36.0 36.1 36.2 Template:Cite journal
  35. 37.0 37.1 37.2 37.3 Template:Cite journal
  36. Template:Cite journal
  37. Template:Cite book
  38. Template:Cite journal
  39. Template:Cite web
  40. Template:Cite journal
  41. Template:Cite journal
  42. Template:Cite book
  43. Template:Cite book
  44. Template:Cite book
  45. 47.0 47.1 47.2 47.3 Template:Cite book
  46. 48.0 48.1 Template:Cite journal
  47. 49.0 49.1 Template:Cite news
  48. Template:Cite news
  49. Template:Cite web
  50. Template:Cite web
  51. Template:Cite journal
  52. Template:Cite book
  53. Template:Cite book
  54. Template:Cite book
  55. Template:Cite book
  56. Template:Cite web
  57. Template:ChemID
  58. Template:Cite book
  59. Template:Cite journal
  60. 62.0 62.1 Template:Cite journal
  61. Template:Cite book
  62. Template:Cite journal
  63. "Does marijuana use affect driving?", National Institute on Drug Abuse, June 2018
  64. Template:Cite journal
  65. Template:Cite web
  66. Template:Cite web
  67. 69.0 69.1 69.2 Template:Cite journal
  68. "Growing Array of Street Drugs Now Laced with Fentanyl", MedPageToday, July 17, 2018
  69. "What Can Marijuana Be Laced With?", American Addiction Centers, updated Nov. 26, 2018
  70. "Is the opioid epidemic now the fentanyl epidemic?", The Baltimore Sun, Dec. 7, 2018
  71. Template:Cite journal
  72. Template:Cite journal
  73. Template:Cite journal
  74. Template:Cite journal
  75. Template:Cite journal
  76. Template:Cite news
  77. Template:Cite book
  78. Template:Cite journal
  79. Template:Cite journal
  80. Template:Cite journal
  81. Template:Cite journal
  82. Template:Cite journal
  83. Template:Cite journal
  84. Template:Cite journal
  85. Template:Cite journal
  86. Template:Cite journal
  87. Template:Cite journal
  88. Template:Cite journal
  89. Template:Cite journal
  90. Template:Cite journal
  91. Template:Cite book
  92. Template:Cite journal
  93. Template:Cite journal
  94. Template:Cite journal
  95. Template:Cite journal
  96. Template:Cite journal
  97. Template:Cite journal
  98. Template:Cite journal
  99. Template:Cite journal
  100. Template:Cite journal
  101. 103.0 103.1 Template:Cite journal
  102. 104.0 104.1 Template:Cite journal
  103. Template:Cite journal
  104. Template:Cite journal
  105. 107.0 107.1 107.2 107.3 Template:Cite journal
  106. Template:Cite journal
  107. Template:Cite journal
  108. Template:Cite journal
  109. Template:Cite journal
  110. 112.0 112.1 Template:Cite journal
  111. Template:Cite journal
  112. Template:Cite journal
  113. Template:Cite journal
  114. Template:Cite journal
  115. Template:Cite journal
  116. 118.0 118.1 Template:Cite journal
  117. Template:Cite journal
  118. Template:Cite journal
  119. Template:Cite journal
  120. Template:Cite news
  121. 123.0 123.1 Template:Cite journal
  122. Template:Cite journal
  123. Template:Cite journal
  124. Template:Cite journal
  125. Template:Cite journal
  126. Template:Cite journal
  127. Template:Cite journal
  128. 130.0 130.1 Template:Cite book
  129. Template:Cite journal
  130. Template:Cite book
  131. Template:Cite journal
  132. Template:Cite journal
  133. Template:Cite book
  134. Template:Cite journal
  135. Template:Cite journal
  136. Template:Cite journal
  137. Template:Cite journal
  138. Template:Cite book
  139. Template:Cite book
  140. https://www.researchgate.net/publication/266888426_The_Non-Specificity_of_the_Duquenois-Levine_Field_Test_for_Marijuana
  141. Template:Cite journal
  142. Template:Cite journal
  143. Template:Cite journal
  144. 146.0 146.1 Template:Cite book
  145. Template:Cite web
  146. Template:Cite journal
  147. 149.0 149.1 149.2 Template:Cite journal
  148. Template:Cite journal
  149. Template:Cite news
  150. Template:Cite journal
  151. Template:Cite news
  152. Template:Cite journal
  153. Template:Cite news
  154. Template:Cite book
  155. Template:Cite book
  156. Template:Cite book
  157. Template:Cite book
  158. Template:Cite book
  159. 161.0 161.1 Template:Cite book
  160. Template:Cite book
  161. Template:Cite book
  162. Template:Cite web
  163. Template:Cite book
  164. Template:Cite book
  165. Template:Cite web
  166. Template:Cite book
  167. Template:Cite web
  168. Template:Cite book
  169. Template:Cite book
  170. Alchimia Blog, Rosin Hash
  171. Template:Cite book
  172. Template:Cite book
  173. Template:Cite book
  174. Template:Cite web
  175. Template:Cite book
  176. Alison Hallett for Wired. Feb. 20, 2013 Hash Oil is Blowing Up Across the U.S. –Literally
  177. Template:Cite book
  178. Template:Cite book
  179. Template:Cite book
  180. Template:Cite book
  181. "Marijuana and the Cannabinoids", ElSohly (p. 8).
  182. Template:Cite book
  183. Template:Cite book
  184. Template:Cite book
  185. Template:Cite book
  186. Template:Cite book
  187. Template:Cite book
  188. Template:Cite book
  189. Template:Cite web
  190. Template:Cite book
  191. Template:Cite book
  192. Template:Cite book
  193. Template:Cite book
  194. Template:Cite book
  195. Template:Cite book
  196. Template:Cite journal
  197. Template:Cite web
  198. Template:Cite canlaw
  199. Template:Cite journal
  200. Template:Google books
  201. Template:USStatute
  202. Template:Cite book
  203. Template:Cite book
  204. Template:Citation
  205. Template:Citation
  206. Template:Cite news
  207. Template:Cite news
  208. Template:Cite book
  209. Template:Cite book
  210. Template:Cite web
  211. "43 Amsterdam coffee shops to close door", Radio Netherlands, Friday 21 November 2008 Template:Webarchive
  212. Template:Cite web
  213. Template:Cite web
  214. Template:Cite web
  215. Template:Cite news
  216. Template:Cite news
  217. Template:Cite web
  218. Template:Cite news
  219. Template:Cite news
  220. Uruguay pharmacies start selling cannabis straight to consumers | World news | The Guardian
  221. Template:Cite web
  222. Template:Cite web
  223. Template:Cite web
  224. 226.0 226.1 Template:Cite web
  225. Alchimia Blog, Medical marijuana news, December 2015
  226. Template:Citation "Podle čl. 36 Jednotné úmluvy o omamných látkách ze dne 31. března 1961 (č. 47/1965 Sb.) se signatáři zavazují k trestnímu postihu tam uvedených forem nakládání s drogami včetně jejich držby. Návrh upouští od dosavadní beztrestnosti držby omamných a psychotropních látek a jedů pro svoji potřebu. Dosavadní beztrestnost totiž eliminuje v řadě případů možnost postihu dealerů a distributorů drog."
  227. Template:Cite web
  228. Template:Cite web
  229. "Dosis máximas de droga para consumo ya están vigentes" Template:Webarchive at El Comercio.com.
  230. "Ecuador: Aprueban tenencia de drogas para consumo" Template:Webarchive at El Nuevo Herald
  231. Template:Cite web
  232. Ley de Narcomenudeo Template:Webarchive, El Pensador Template:Es icon, 17 October 2009
  233. Mexico: The Law Against Small-Scale Drug Dealing. A Doubtful Venture, Jorge Hernández Tinajero & Carlos Zamudio Angles, Series on Legislative Reform of Drug Policies Nr. 3, November 2009
  234. Template:Cite web
  235. Template:Cite news
  236. 238.0 238.1 238.2 Template:Cite book
  237. 239.0 239.1 Template:Cite journal
  238. Template:Cite web
  239. 241.0 241.1 241.2 Template:Cite web
  240. Template:Cite web
  241. Template:Cite journal Ch. 2.3.
  242. Template:Cite web
  243. Template:Cite journal
  244. Template:Cite journal
  245. Template:Cite journal
  246. Template:Cite book
  247. Template:Cite book
  248. 250.0 250.1 Template:Cite journal
  249. Template:Cite book
  250. Template:Cite web
  251. Template:Cite book
  252. Template:Cite journalTemplate:Dead link
  253. Template:Cite journal
  254. Template:Cite web
  255. Template:Cite journal
  256. Template:Cite web
  257. Template:Cite journal
  258. Template:Cite journal
  259. Template:Cite journal
  260. Template:Cite journal
  261. Template:Cite news
  262. Template:Cite web
  263. Template:Cite web
  264. Template:Cite journal
  265. Template:Cite web
  266. Template:Cite journal
  267. Template:Cite journal
  268. Template:Cite book
  269. Template:Cite news
  270. Template:Cite journal
  271. Template:Cite journal
  272. Template:Cite journal
  273. Template:Cite news
  274. Template:Cite news

External links

Template:Wiktionary Template:Commonscat-inline

Template:Cannabis Template:Cannabinoids Template:Cannabinoid receptor modulators Template:Analgesics Template:Euphoriants Template:Psychoactive substance use Template:Drug use Template:Portalbar Template:Authority control